Correction: Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China

Saved in:
Bibliographic Details
Published in:BMC medicine 2024-10, Vol.22 (1), p.465-2, Article 465
Main Authors: Song, Yanhua, Shu, Wei, Pei, Yi, Du, Juan, Wu, Guihui, Wang, Hua, Mi, Fengling, Liu, Fangchao, Ma, Liping, Xie, Li, Kong, Zhongshun, Wu, Xiaoguang, Liu, Rongmei, Chen, Hongmei, Li, Hua, Ge, Qiping, Nie, Lihui, Lv, Zizheng, Huang, Xuerui, Li, Mingwu, Jiang, Mingying, Chen, Xiaohong, Cai, Qingshan, Chen, Wei, Liu, Yanmei, Miao, Yanfang, Tang, Yan, Chen, Yu, Geng, Shujun, Zhou, Quanying, Liu, Yuhong, Pang, Yu, Gao, Mengqiu
Format: Article
Language:English
Subjects:
Cancer
Chemotherapy
Levofloxacin
Tuberculosis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1741-7015
1741-7015
DOI:10.1186/s12916-024-03694-4